BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35163491)

  • 1. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.
    Benhassine M; Le-Bel G; Guérin SL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the proteasome activity and the turnover of the serotonin receptor 2B (HTR2B) in human uveal melanoma.
    Le-Bel G; Benhassine M; Landreville S; Guérin SL
    Exp Eye Res; 2019 Jul; 184():72-77. PubMed ID: 31002821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of the Human 5-Hydroxytryptamine Receptor 2B (HTR2B) Gene Is under the Regulatory Influence of the Transcription Factors NFI and RUNX1 in Human Uveal Melanoma.
    Benhassine M; Guérin SL
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
    Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
    Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
    Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of the poly(ADP-ribosyl)ation enzymes in uveal melanoma and regulation of PARG gene expression by the transcription factor ERM.
    Molloy-Simard V; St-Laurent JF; Vigneault F; Gaudreault M; Dargis N; Guérin MC; Leclerc S; Morcos M; Black D; Molgat Y; Bergeron D; de Launoit Y; Boudreau F; Desnoyers S; Guérin S
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6219-31. PubMed ID: 22915039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis.
    Guenterberg KD; Grignol VP; Raig ET; Zimmerer JM; Chan AN; Blaskovits FM; Young GS; Nuovo GJ; Mundy BL; Lesinski GB; Carson WE
    Mol Cancer Ther; 2010 Feb; 9(2):510-20. PubMed ID: 20103601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.
    Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
    Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
    Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of focal adhesion kinase in uveal melanoma and the effects of Hsp90 inhibition by 17-AAG.
    Faingold D; Filho VB; Fernandes B; Jagan L; de Barros AM; Orellana ME; Antecka E; Burnier MN
    Pathol Res Pract; 2014 Nov; 210(11):739-45. PubMed ID: 25041838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
    Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
    BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein-I promoter involved in interleukin-6-induced gene expression.
    Lee DK; Carrasco J; Hidalgo J; Andrews GK
    Biochem J; 1999 Jan; 337 ( Pt 1)(Pt 1):59-65. PubMed ID: 9854025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
    Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth proteomic profiling of the uveal melanoma secretome.
    Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
    Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
    Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
    J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.